0102030405
Company News
UBT251 vs Retatrutide: The Next Chapter in Triple-Agonist Obesity Research
2026-07-22
The development of obesity medicines is moving rapidly beyond conventional GLP-1 receptor agonists. After single-receptor treatments such as semaglutide and dual GLP-1/GIP agonists such as tirzep...
view
detail
Thai Distributor Places Order for SLU-PP-332
2026-04-06
A distributor from Thailand recently placed a trial order for SLU-PP-332 after reviewing our catalogue and discussing stock availability, supporting documents, and shipment details with our team....
view
detail
Canadian Customer Tests CAS: 61-54-1 and CAS: 608-07-1 Before Bulk Purchase
2026-04-06
We are pleased to share that a customer from Canada recently placed a trial order for CAS: 61-54-1 and CAS: 608-07-1 for quality evaluation. This initial order marks the first step toward potenti...
view
detail
BPC-157 and TB-500: An Introduction to Basic Research and Application Directions
2026-04-01
BPC-157 and TB-500: An Introduction to Basic Research and Application Directions
view
detail
What Is a Lyophilizer? Working Principle, Process, and Advantage
2026-04-01
What Is a Lyophilizer? Working Principle, Process, and Advantage
view
detail
Procurement process
2026-03-30
Step 1: Contact Us
Send us your inquiry by WhatsApp, email, or through our website, and tell us which products you need.
Step 2: Get a Quotation
We will send you the product details, pricing...
view
detail
Reliable Cosmetic Raw Material Supply for Modern Beauty Brands
2026-03-29
Reliable Cosmetic Raw Material Supply for Modern Beauty Brands
As the global beauty and personal care market continues to expand, brands are placing greater emphasis on ingredient quality, produ...
view
detail
Customer inquiry → Shipment arranged → Parcel delivered successfully
2026-03-24
Real customer inquiry. Real delivery. Real feedback.
From inquiry to delivery, we always do our best to provide fast response and reliable shipping service.
✔ Product inquiry received✔ Fast...
view
detail
The triple targets have sparked a new revolution in metabolic therapy. The clinical data of Retatrutide (2381089-83-2) is astonishing, leading a wave of industrial layout
2026-03-12
Against the backdrop of the continuous iteration and upgrading of the global GLP-1 class drug race, triple-target agonists, with their unique advantage of synergistic enhancement, have emerged as...
view
detail
The GLP-1 track continues to heat up, and Semaglutide (910463-68-2) has made multiple breakthroughs, empowering metabolic health and multi-field scientific research innovation
2026-03-12
In recent years, the global GLP-1 (glucagon-like peptide-1) receptor agonist field has continued to explode. As a core benchmark product in this field, Semaglutide (CAS number: Semaglutide) With ...
view
detail